BA
Brian Abrahams RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
94
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
55%
Neutral
45%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $31 |
121%
upside
| 1 | +33% |
0
%
| 7 Mar ‘25 7 months ago |
|
|
|
Sector Perform
Maintained
| $3 |
83%
upside
| 2 | – |
–
| 4 Mar ‘25 7 months ago |
|
|
|
Sector Perform
Reiterated
| $4 |
121%
upside
| 2 | -85% |
0
%
| 4 Mar ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $143 |
9%
upside
| 2 | +14% |
0
%
| 3 Feb ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $40 |
6%
upside
| 1 | +67% |
0
%
| 28 Jan ‘25 8 months ago |
|
|
|
Sector Perform
Downgraded
| $132 |
0%
upside
| 1 | +75% |
–
| 22 Jan ‘25 9 months ago |
|
|
|
Sector Perform
Downgraded
| $1.50 | – | 1 | -61% |
–
| 10 Jan ‘25 9 months ago |
|
|
|
Sector Perform
Downgraded
| $2 | – | 2 | -32% |
0
%
| 20 Dec ‘24 10 months ago |
|
|
|
Sector Perform
Upgraded
| $4 |
54%
downside
| 1 | +30% |
–
| 21 Nov ‘24 11 months ago |
|
|
|
Sector Perform
Maintained
| $30 |
13%
downside
| 1 | – |
–
| 1 Nov ‘24 11 months ago |
|
|
|
Sector Perform
Maintained
| $1 |
82%
upside
| 1 | – |
–
| 25 Oct ‘24 1 year ago |
|